B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 25.24 HKD -4.39%
Market Cap: 10.1B HKD

Intrinsic Value

The intrinsic value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock under the Base Case scenario is 14.76 HKD. Compared to the current market price of 25.24 HKD, Biocytogen Pharmaceuticals Beijing Co Ltd is Overvalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
14.76 HKD
Overvaluation 42%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Biocytogen Pharmaceuticals Beijing Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Biocytogen Pharmaceuticals Beijing Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Biocytogen Pharmaceuticals Beijing Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biocytogen Pharmaceuticals Beijing Co Ltd.

Explain Valuation
Compare Biocytogen Pharmaceuticals Beijing Co Ltd to

Fundamental Analysis

Biocytogen Pharmaceuticals Beijing Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Biocytogen Pharmaceuticals Beijing Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Biocytogen Pharmaceuticals Beijing Co Ltd

Balance Sheet Decomposition
Biocytogen Pharmaceuticals Beijing Co Ltd

Current Assets 889.9m
Cash & Short-Term Investments 521m
Receivables 224.2m
Other Current Assets 144.6m
Non-Current Assets 1.6B
Long-Term Investments 147.9m
PP&E 1.4B
Intangibles 17m
Other Non-Current Assets 79.9m
Current Liabilities 471.3m
Accounts Payable 104.6m
Accrued Liabilities 26.8m
Other Current Liabilities 339.9m
Non-Current Liabilities 1.1B
Long-Term Debt 429.7m
Other Non-Current Liabilities 695.1m
Efficiency

Free Cash Flow Analysis
Biocytogen Pharmaceuticals Beijing Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biocytogen Pharmaceuticals Beijing Co Ltd

Revenue
1.2B CNY
Cost of Revenue
-272.9m CNY
Gross Profit
918m CNY
Operating Expenses
-702.5m CNY
Operating Income
215.4m CNY
Other Expenses
-83.2m CNY
Net Income
132.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Biocytogen Pharmaceuticals Beijing Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive ROE
Healthy Operating Margin
41/100
Profitability
Score

Biocytogen Pharmaceuticals Beijing Co Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Biocytogen Pharmaceuticals Beijing Co Ltd's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Short-Term Solvency
Negative Net Debt
57/100
Solvency
Score

Biocytogen Pharmaceuticals Beijing Co Ltd's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Biocytogen Pharmaceuticals Beijing Co Ltd

There are no price targets for Biocytogen Pharmaceuticals Beijing Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Biocytogen Pharmaceuticals Beijing Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Biocytogen Pharmaceuticals Beijing Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock?

The intrinsic value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock under the Base Case scenario is 14.76 HKD.

Is Biocytogen Pharmaceuticals Beijing Co Ltd stock undervalued or overvalued?

Compared to the current market price of 25.24 HKD, Biocytogen Pharmaceuticals Beijing Co Ltd is Overvalued by 42%.

Back to Top